Hap Trading, LLC Aldeyra Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$3.25 - $5.17 $32,825 - $52,217	-10,100 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.5 - $9.63 $137,550 - $378,459	-39,300 Reduced 79.55%	10,100 $1,000
Q3 2021 Nov 10, 2021	BUY	$7.94 - $11.31 $115,924 - $165,126	14,600 Added 41.95%	49,400 $30,000
Q2 2021 Aug 11, 2021	BUY	$10.44 - $14.85 $363,312 - $516,780	34,800 New	34,800 $37,000
Q1 2021 May 14, 2021	SELL	$6.53 - $14.42 $75,748 - $167,272	-11,600 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.31 - $8.13 $73,196 - $94,308	11,600 New	11,600 $18,000

127

37.6M

757K

539K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $390M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.